BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29196860)

  • 1. Role of Thrombin in Soluble Thrombomodulin-Induced Suppression of Peripheral HMGB1-Mediated Allodynia in Mice.
    Tsujita R; Tsubota M; Hayashi Y; Saeki H; Sekiguchi F; Kawabata A
    J Neuroimmune Pharmacol; 2018 Jun; 13(2):179-188. PubMed ID: 29196860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants.
    Tsubota M; Fukuda R; Hayashi Y; Miyazaki T; Ueda S; Yamashita R; Koike N; Sekiguchi F; Wake H; Wakatsuki S; Ujiie Y; Araki T; Nishibori M; Kawabata A
    J Neuroinflammation; 2019 Oct; 16(1):199. PubMed ID: 31666085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human soluble thrombomodulin-induced blockade of peripheral HMGB1-dependent allodynia in mice requires both the lectin-like and EGF-like domains.
    Hayashi Y; Tsujita R; Tsubota M; Saeki H; Sekiguchi F; Honda G; Kawabata A
    Biochem Biophys Res Commun; 2018 Jan; 495(1):634-638. PubMed ID: 29146186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of high-mobility group box 1 and its modulation by thrombomodulin/thrombin axis in neuropathic and inflammatory pain.
    Tsujita R; Tsubota M; Sekiguchi F; Kawabata A
    Br J Pharmacol; 2021 Feb; 178(4):798-812. PubMed ID: 32374414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats.
    Nishida T; Tsubota M; Kawaishi Y; Yamanishi H; Kamitani N; Sekiguchi F; Ishikura H; Liu K; Nishibori M; Kawabata A
    Toxicology; 2016 Jul; 365():48-58. PubMed ID: 27474498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral HMGB1-induced hyperalgesia in mice: Redox state-dependent distinct roles of RAGE and TLR4.
    Yamasoba D; Tsubota M; Domoto R; Sekiguchi F; Nishikawa H; Liu K; Nishibori M; Ishikura H; Yamamoto T; Taga A; Kawabata A
    J Pharmacol Sci; 2016 Feb; 130(2):139-42. PubMed ID: 26883456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder pain relief by HMGB1 neutralization and soluble thrombomodulin in mice with cyclophosphamide-induced cystitis.
    Tanaka J; Yamaguchi K; Ishikura H; Tsubota M; Sekiguchi F; Seki Y; Tsujiuchi T; Murai A; Umemura T; Kawabata A
    Neuropharmacology; 2014 Apr; 79():112-8. PubMed ID: 24262631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats.
    Tanaka J; Seki Y; Ishikura H; Tsubota M; Sekiguchi F; Yamaguchi K; Murai A; Umemura T; Kawabata A
    Br J Pharmacol; 2013 Nov; 170(6):1233-41. PubMed ID: 24004409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk.
    Sekiguchi F; Domoto R; Nakashima K; Yamasoba D; Yamanishi H; Tsubota M; Wake H; Nishibori M; Kawabata A
    Neuropharmacology; 2018 Oct; 141():201-213. PubMed ID: 30179591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes.
    Ito T; Kawahara K; Okamoto K; Yamada S; Yasuda M; Imaizumi H; Nawa Y; Meng X; Shrestha B; Hashiguchi T; Maruyama I
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1825-30. PubMed ID: 18599803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a role for spinal HMGB1 in ischemic stress-induced mechanical allodynia in mice.
    Matsuura W; Harada S; Liu K; Nishibori M; Tokuyama S
    Brain Res; 2018 May; 1687():1-10. PubMed ID: 29476751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling.
    Herzog C; Lorenz A; Gillmann HJ; Chowdhury A; Larmann J; Harendza T; Echtermeyer F; Müller M; Schmitz M; Stypmann J; Seidler DG; Damm M; Stehr SN; Koch T; Wollert KC; Conway EM; Theilmeier G
    Cardiovasc Res; 2014 Mar; 101(3):400-10. PubMed ID: 24323314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy.
    Sekiguchi F; Kawabata A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 Axis.
    Irie Y; Tsubota M; Ishikura H; Sekiguchi F; Terada Y; Tsujiuchi T; Liu K; Nishibori M; Kawabata A
    J Neuroimmune Pharmacol; 2017 Dec; 12(4):693-707. PubMed ID: 28755135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4.
    Ma F; Kouzoukas DE; Meyer-Siegler KL; Westlund KN; Hunt DE; Vera PL
    BMC Physiol; 2017 May; 17(1):6. PubMed ID: 28545586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic Expression of Human Thrombomodulin Inhibits HMGB1-Induced Porcine Aortic Endothelial Cell Activation.
    Bongoni AK; Klymiuk N; Wolf E; Ayares D; Rieben R; Cowan PJ
    Transplantation; 2016 Sep; 100(9):1871-9. PubMed ID: 27077599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone IIA Attenuates Chronic Pancreatitis-Induced Pain in Rats via Downregulation of HMGB1 and TRL4 Expression in the Spinal Cord.
    Wang YS; Li YY; Wang LH; Kang Y; Zhang J; Liu ZQ; Wang K; Kaye AD; Chen L
    Pain Physician; 2015; 18(4):E615-28. PubMed ID: 26218952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhizin ameliorates inflammatory pain by inhibiting microglial activation-mediated inflammatory response via blockage of the HMGB1-TLR4-NF-kB pathway.
    Sun X; Zeng H; Wang Q; Yu Q; Wu J; Feng Y; Deng P; Zhang H
    Exp Cell Res; 2018 Aug; 369(1):112-119. PubMed ID: 29763588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 and its membrane receptors as therapeutic targets in an intravesical substance P-induced bladder pain syndrome mouse model.
    Irie Y; Tsubota M; Maeda M; Hiramoto S; Sekiguchi F; Ishikura H; Wake H; Nishibori M; Kawabata A
    J Pharmacol Sci; 2020 Jun; 143(2):112-116. PubMed ID: 32222337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
    Festoff BW; Sajja RK; van Dreden P; Cucullo L
    J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.